@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HGD6GZ6P-K skos:prefLabel "Antihistaminiques des récepteurs H1"@fr, "Histamine H1 Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-PFLXXSV3-F skos:prefLabel "Anti-Allergic Agents"@en, "Antiallergiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-KGXRH1R8-K mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-G4R176S9-J, jvr:-S0CS1X5R-5, jvr:-NKM836P1-M, jvr:-Q3979798-W, jvr:-THHNVC7V-3, jvr:-NHL3D2X0-S, jvr:-NFTHND7Q-8, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-FWD2BGQ0-9, jvr:-W6SQV79N-S, jvr:-R0ZCQ8X6-J, jvr:-WK5F724J-1, jvr:-D0F21513-5, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-CB30NGKB-3, jvr:-M63HSDM7-1, jvr:-G30ZJ446-J, jvr:-SBNWSM1T-R, jvr:-H7K65Q8S-Z, jvr:-BT300B3G-Q, jvr:-T9HQD7ST-J, jvr:-L6C0XPHT-4 ; skos:altLabel "Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-"@fr, "Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-"@en, "2L8T9S52QM"@fr, "2L8T9S52QM"@en, "486-12-4 (Triprolidine)"@fr, "486-12-4 (Triprolidine)"@en, "NG7A104R3J"@fr, "NG7A104R3J"@en, "51366-19-9 (trans-isomer, oxalate)"@en, "51366-19-9 (trans-isomer, oxalate)"@fr, "6138-79-0 (mono-HCl, mono-hydrate)"@fr, "6138-79-0 (mono-HCl, mono-hydrate)"@en, "13573-69-8 ((Z)-isomer)"@fr, "13573-69-8 ((Z)-isomer)"@en, "14465-07-7 (oxalate)"@fr, "14465-07-7 (oxalate)"@en, "YAN7R5L890"@fr, "YAN7R5L890"@en, "51657-91-1 (mono-HCl, (Z)-isomer)"@fr, "51657-91-1 (mono-HCl, (Z)-isomer)"@en ; owl:sameAs ; skos:definition "Histamine H1 antagonist used in allergic rhinitis; ASTHMA; and URTICARIA. It is a component of COUGH and COLD medicines. It may cause drowsiness."@en ; skos:hiddenLabel "Triprolidine Monohydrochloride, (Z)-Isomer"@en, "Triprolidine Monohydrochloride"@en, "Chlorhydrate de triprolidine anhydre"@fr, "Triprolidine Oxalate"@en, "Oxalate de triprolidine"@fr, "Triprolidine, (Z)-Isomer"@en, "Pro Actidil"@en, "Triprolidine Oxalate, (trans)-Isomer"@en, "Triprolidine Monohydrochloride, Monohydrate"@en, "Triprolidine Hydrochloride"@en, "Chlorhydrate de triprolidine"@fr, "Triprolidine Hydrochloride Anhydrous"@en, "Actidil"@en ; a mesh:Descriptor, skos:Concept ; skos:inScheme jvr: ; dc:created "1999-01-01"^^xsd:date ; mesh:pharmacologicalAction jvr:-HGD6GZ6P-K, jvr:-PFLXXSV3-F ; skos:broader jvr:-P551XG36-F ; skos:prefLabel "Triprolidine"@fr, "Triprolidine"@en ; dc:established "1991-01-01"^^xsd:date ; dc:modified "2017-05-24"^^xsd:date . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-P551XG36-F skos:prefLabel "Pyridines"@fr, "Pyridines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-KGXRH1R8-K . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .